BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12142788)

  • 1. Treatment of metastatic rhabdoid tumor of the kidney.
    Wagner L; Hill DA; Fuller C; Pedrosa M; Bhakta M; Perry A; Dome JS
    J Pediatr Hematol Oncol; 2002; 24(5):385-8. PubMed ID: 12142788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
    Yamamoto M; Suzuki N; Hatakeyama N; Mizue N; Hori T; Kuroiwa Y; Hareyama M; Oda T; Kudoh T; Nui A; Matsuno T; Hirama T; Yokoyama S; Dome JS; Tsutsumi H
    J Pediatr Hematol Oncol; 2006 May; 28(5):286-9. PubMed ID: 16772877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
    Koga Y; Matsuzaki A; Suminoe A; Hatano M; Saito Y; Kinoshita Y; Tajiri T; Taguchi T; Kohashi K; Oda Y; Tsuneyoshi M; Hara T
    Pediatr Blood Cancer; 2009 Jul; 52(7):888-90. PubMed ID: 19260106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
    Hernández-Marqués C; Lassaletta A; Cormenzana M; García-Esparza E; Madero-López L
    Pediatr Hematol Oncol; 2015 Apr; 32(3):193-8. PubMed ID: 24852450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordant rhabdoid tumor of the kidney in a set of identical twins with discordant outcomes.
    Sahdev I; James-Herry A; Scimeca P; Parker R
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):491-4. PubMed ID: 12794530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pleural mesothelioma in a child: long-term survival with ICE-WAC chemotherapy regimen.
    Mutafoğlu-Uysal K; Kargi A; Sarialioğlu F; Olgun N; Kovanlikaya A
    Turk J Pediatr; 2002; 44(3):244-7. PubMed ID: 12405438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdoid tumor of the kidney presenting with hemiplegia: report of a case.
    Alavi S; Rashidi A; Khatami AR; Arzanian MT
    Pediatr Hematol Oncol; 2007 Mar; 24(2):123-8. PubMed ID: 17454778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group.
    van den Heuvel-Eibrink MM; van Tinteren H; Rehorst H; Coulombe A; Patte C; de Camargo B; de Kraker J; Leuschner I; Lugtenberg R; Pritchard-Jones K; Sandstedt B; Spreafico F; Graf N; Vujanic GM
    Pediatr Blood Cancer; 2011 May; 56(5):733-7. PubMed ID: 21370404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
    Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
    Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of a patient with stage IV rhabdoid tumor of the kidney: case report and review.
    Waldron PE; Rodgers BM; Kelly MD; Womer RB
    J Pediatr Hematol Oncol; 1999; 21(1):53-7. PubMed ID: 10029814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapse.
    Hosoi H; Iehara T; Tsuchiya K; Misawa A; Miyaji M; Yagyu S; Koizumi M; Nishimura T; Tokiwa K; Iwai N; Yanagisawa A; Sugimoto T
    J Pediatr Surg; 2007 Oct; 42(10):E9-12. PubMed ID: 17923188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining therapeutic strategies for patients with resistant Wilm's tumor.
    Marina NM; Wilimas JA; Meyer WH; Jones DP; Douglass EC; Pratt CB
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):296-300. PubMed ID: 7978044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
    Daw NC; Gregornik D; Rodman J; Marina N; Wu J; Kun LE; Jenkins JJ; McPherson V; Wilimas J; Jones DP
    Eur J Cancer; 2009 Jan; 45(1):99-106. PubMed ID: 18996004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
    Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
    Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide.
    Gururangan S; Bowman LC; Parham DM; Wilimas JA; Rao B; Pratt CB; Douglass EC
    Cancer; 1993 Apr; 71(8):2653-9. PubMed ID: 8453588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
    Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
    Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2.
    Benedetti DJ; Renfro LA; Tfirn I; Daw NC; Kalapurakal JA; Ehrlich PF; Khanna G; Perlman E; Warwick A; Gow KW; Paulino AC; Seibel NL; Grundy P; Fernandez CV; Geller JI; Mullen EA; Dome JS
    Cancer; 2024 Jul; 130(13):2361-2371. PubMed ID: 38396300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary rhabdomyosarcoma of the temporal bone].
    Lorenzo Núñez R; Ramos Benavente MD; Morales Jiménez C; Ruiz Medina E
    Acta Otorrinolaringol Esp; 1995; 46(1):53-6. PubMed ID: 7734166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.